258 related articles for article (PubMed ID: 28057863)
1. Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.
Koenig P; Lee CV; Walters BT; Janakiraman V; Stinson J; Patapoff TW; Fuh G
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E486-E495. PubMed ID: 28057863
[TBL] [Abstract][Full Text] [Related]
2. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the evolution of an antibody combining site.
Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC
Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human germline antibody 3-23/B3.
Malia TJ; Obmolova G; Almagro JC; Gilliland GL; Teplyakov A
Mol Immunol; 2011 Jul; 48(12-13):1586-8. PubMed ID: 21605907
[TBL] [Abstract][Full Text] [Related]
5. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
6. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
[TBL] [Abstract][Full Text] [Related]
7. The structure of a LAIR1-containing human antibody reveals a novel mechanism of antigen recognition.
Hsieh FL; Higgins MK
Elife; 2017 May; 6():. PubMed ID: 28527239
[TBL] [Abstract][Full Text] [Related]
8. Structural and energetic hot-spots for the interaction between a ladder-like polycyclic ether and the anti-ciguatoxin antibody 10C9Fab.
Ui M; Tanaka Y; Tsumuraya T; Fujii I; Inoue M; Hirama M; Tsumoto K
Mol Biosyst; 2011 Mar; 7(3):793-8. PubMed ID: 21161086
[TBL] [Abstract][Full Text] [Related]
9. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
10. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response.
Sethi DK; Agarwal A; Manivel V; Rao KV; Salunke DM
Immunity; 2006 Apr; 24(4):429-38. PubMed ID: 16618601
[TBL] [Abstract][Full Text] [Related]
11. Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.
Zimmermann J; Oakman EL; Thorpe IF; Shi X; Abbyad P; Brooks CL; Boxer SG; Romesberg FE
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13722-7. PubMed ID: 16954202
[TBL] [Abstract][Full Text] [Related]
12. Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.
Addis PW; Hall CJ; Bruton S; Veverka V; Wilkinson IC; Muskett FW; Renshaw PS; Prosser CE; Carrington B; Lawson ADG; Griffin R; Taylor RJ; Waters LC; Henry AJ; Carr MD
J Biol Chem; 2014 Mar; 289(10):7200-7210. PubMed ID: 24436329
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of antibody-antigen interactions.
Sundberg EJ
Methods Mol Biol; 2009; 524():23-36. PubMed ID: 19377934
[TBL] [Abstract][Full Text] [Related]
14. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
15. Antibody Structure.
Stanfield RL; Wilson IA
Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105818
[TBL] [Abstract][Full Text] [Related]
16. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
[TBL] [Abstract][Full Text] [Related]
17. Rigidity Emerges during Antibody Evolution in Three Distinct Antibody Systems: Evidence from QSFR Analysis of Fab Fragments.
Li T; Tracka MB; Uddin S; Casas-Finet J; Jacobs DJ; Livesay DR
PLoS Comput Biol; 2015 Jul; 11(7):e1004327. PubMed ID: 26132144
[TBL] [Abstract][Full Text] [Related]
18. Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex.
Kiyoshi M; Caaveiro JM; Miura E; Nagatoishi S; Nakakido M; Soga S; Shirai H; Kawabata S; Tsumoto K
PLoS One; 2014; 9(1):e87099. PubMed ID: 24475232
[TBL] [Abstract][Full Text] [Related]
19. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutation, affinity maturation and the antibody repertoire: a computer model.
Weinand RG
J Theor Biol; 1990 Apr; 143(3):343-82. PubMed ID: 2385109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]